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Background: Varicose veins are common and increasingly are being treated by less invasive endoscopic methods such as
foam sclerotherapy. Patent foramen ovale (PFO) is also common, present in approximately one-quarter of adults. PFO
allows bubbles introduced by foam sclerotherapy to cross into the general circulation, potentially causing cerebral artery
gas embolization with unevaluated consequences.
Methods: Men and women aged 18 to 60 years with symptomatic varicose veins (CEAP C3-5) responded to an
advertisement to recruit volunteers for a study on endovenous microfoam ablation (EMA). Participants’ veins were
screened by duplex ultrasound imaging, and those with isolated great saphenous vein (GSV) incompetence were tested for
right-to-left (R-L) vascular shunt using transcranial Doppler (TCD) of the middle cerebral artery to detect the presence
of bubble emboli after an injection of an agitated saline, blood, and air mixture as a contrast at rest and with the Valsalva
maneuver.
Results: Of 221 participants tested for R-L shunt, 85 (38.5%) were positive at rest (95% confidence interval [CI],
32.5-45.2) and 114 (51.8%) were positive after the Valsalva maneuver (95% CI, 45.4-58.5). A total 130 patients (58.8%)
were positive for R-L shunt at rest or after Valsalva (95% CI, 52.5%-65.1%). This is significantly higher than the reported
26% prevalence of PFO in the general population (95% CI, 24.4-30.1).
Conclusions: The prevalence of R-L shunt in patients with GSV incompetence CEAP C3-5 in this study was higher than
expected in the general population. TCD does not differentiate between intracardiac shunts and intrapulmonary shunts,
so this observation needs further investigation. This link between R-L shunt and varicose veins is novel and, whether
etiologic or functional, may improve the understanding of both conditions. The findings have importance in the
treatment of varicose veins with foam sclerotherapy and EMA. (J Vasc Surg 2010;51:104-7.)Patent foramen ovale (PFO) is common in the general
population: in 11 studies totalling 9262 autopsies, the
prevalence was 26% (range, 15%-32%).1 Although PFO has
been considered a benign congenital cardiac abnormality
that is rarely associated with any adverse consequences, it is
known to be associated with cryptogenic stroke in adults
aged 55 years, with a prevalence of up to 56%.2 The
prevalence decreases with age from 35% in the first 3
decades, 25% in the next 5 decades, and approximately 20%
in age80 years,3,4 suggesting that either that PFOs close
in adult life or that they are associated with premature
death.
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104As the diagnosis of PFO has been facilitated by the use
of contrast ultrasound imaging methods, PFO has been
found to be associated with migraine,5,6 dementia,7 and an
increased number of brain lesions on magnetic resonance
imaging in recreational divers,8,9 all postulated to be caused
by microemboli crossing through a venous (R) to arterial
(L) circulation (R-L) shunt. Repair of the PFO has been
proposed to reduce migraine attacks,10 but not all studies
have been supportive.11
Endovenous microfoam ablation (EMA) for the treat-
ment of varicose veins caused by trunk vein incompetence
has been rapidly adopted in Europe after early publications
by Cabrera et al.12 Millions of small bubbles are introduced
into the venous circulation during EMA. If the foam or
microfoam is prepared with room air,13 most of the gas is
nitrogen, which is sparingly soluble and may embolize to
the brain through a R-L shunt.
In a series of patients treated with a proprietary micro-
foam under United States Food and Drug Administration
(FDA) Investigation of NewDrug (IND) regulations, bub-
bles were detected by transthoracic echocardiography in
the right side of the heart in all patients. In one patient,
bubbles were seen to cross into the left circulation and were
identified by continuous-wave Doppler ultrasound imag-
ing in the carotid artery.14 Transesophageal echocardiog-
raphy (TEE) showed this patient had a small PFO. In
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sound appearances of bubbles in patients after treatment
for varicose veins by EMA, patients with PFO were specif-
ically excluded by screening for PFO by both transthoracic
echocardiography and transcranial Doppler (TCD) ultra-
sound. The prevalence of PFO was higher than expected in
the patients screened for this study: 25 of 66 (42.7%; 95%
confidence interval [CI], 31.5%-55.9%) had PFO, suggest-
ing a statistically higher prevalence than in the general
population.15
Although bubble emboli might be considered innocu-
ous, there is one case report of a stroke after air-based foam
sclerotherapy of the GSV16 and another of two patients
who presented with serious neurologic symptoms after
injections of small volumes (4 and 10 mL) of air-based
sclerosant foam. Both patients had demonstrable gas in the
cerebral circulation on computed tomography scanning and
both were shown to have previously undiagnosed PFO.17
We explored the relationship between R-L shunt and
varicose veins further in patients recruited to a study of
EMA treatment of symptomatic varicose veins due to GSV
incompetence that used a proprietary polidocanol micro-
foam (Varisolve, BTG International Ltd, London, United
Kingdom). All participants who fulfilled the general entry
criteria were screened for R-L shunt with contrast TCD.
MATERIALS AND METHODS
Ethics. The study was conducted under the standards
of the International Conference on Harmonisation, Good
Clinical Practice. All sites obtained local Investigational
Review Board approval for the protocol, and all participants
signed approved informed consent. An independent Data
Safety and Monitoring Board was established to review
adverse events.
Patients. Between March 2007 and May 2008, 545
patients were recruited at five investigational sites and un-
derwent screening. Entry criteria, including symptomatic
varicose veins (CEAP C3-5), duplex ultrasound (DU) ve-
nous examination confirming isolated symptomatic GSV
incompetence, and completion of TCD examination, were
fulfilled by 221 patients. Their demographics were typical
of varicose vein patients presenting for treatment, with a
mean age of 46.2 years (range, 21-61 years) and 95% of
patients between 30 and 60 years old, 76% women, and
92% white.
Shunt investigation. The test was administered by
Registered Vascular Technologists (RVT) who had been
prequalified by a TCD expert (A. R.) before the start of the
study. The R-L shunt investigation was performed in a
semi-recumbent position at rest and after a standardized
Valsalva maneuver. Unilateral middle cerebral artery mon-
itoring using a 2-MHz probe held in a head frame
(Doppler-Box, Compumedics, GmbH, Singen, Germany) was
used to detect the presence of bubble emboli as high-
intensity transient signals (HITS). Agitated saline for the
contrast TCD test was prepared by rapidly transferring 8
mL of normal saline, 1 mL of room air, and 1 mL of thepatient’s blood between two 10-mL syringes, connected by
an open three-way tap, before injecting it into an antecu-
bital vein as a bolus. An R-L shunt was confirmed if the
patient had one or more HITS within 15 cardiac cycles of
injection of contrast at rest or after release of Valsalva. The
Valsalva strain was started 5 seconds after contrast injection
and maintained for 10 seconds at 40 mmHg before release
and resumption of normal breathing according to the Con-
sensus Conference.18Unsatisfactory or equivocal tests were
repeated at the discretion of the investigator. The timing of
the arrival and the number of HITS was recorded, and a
modified Spencer grading19 was used to categorize the
severity of the shunt at rest and after Valsalva.
Microfoam administration. Patients subsequently
received treatment with polidocanol endovenous micro-
foam, up to a maximum of 20 mL, 1% polidocanol, O2/
CO2 microfoam (Varisolve under FDA IND). The GSV
was cannulated in the middle thigh, the leg was elevated,
and an initial proximal injection was made. When micro-
foam was seen on ultrasound imaging 5 cm from the
saphenofemoral junction, the GSV was compressed using
the ultrasound probe, and the injection was stopped. Fur-
ther injections, up to a maximum of 20 mL, were made to
fill the distal GSV trunk and varicosities. TCD monitoring
of the middle cerebral artery was continuously maintained
during the procedure and continued for three 10-minute
periods: after treatment, immediately before, and after two
10-minute periods of ambulation.
RESULTS
Of the 224 patients entered for TCD screening, three
had no temporal bone window, leaving 221 patients with
TCD data. Of these, 85 (38.5%) were positive at rest (95%
CI, 32.5-45.2), and 44 were classified Spencer grade 1 (1-5
HITS), declining in frequency to nine (4%) at grade 5
(150 HITS). After the Valsalva maneuver, 114 (51.8%)
were positive (95% CI, 45.4-58.5), 29 were grade 1, 25
were grade 4, and 29 were grade 5 (Table I).
The R-L shunt test was positive in 130 patients
(58.9%), either at rest or after Valsalva (95% CI, 52.5-
65.1), 91 patients were negative both at rest and with
Table I. Spencer grading of right-to-left shunt at rest
and with Valsalvaa
Spencer grading system No. with Spencer grade
Grade No. of HITS At rest After Valsalva
0 0 136 106
1 1-5 44 29
2 6-10 10 17
3 11-50 13 15
4 51-150 9 24
5 150 9 28b
HITS, High-intensity transient signals.
aSome patients positive after Valsalva were negative at rest, and vice versa.
bOne patient grade 5 at rest did not have the test repeated with Valsalva.Valsalva, and 15 were grade 1 at rest but negative on
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with Valsalva. Most of these were low-grade shunts, but
nine of 136 (6.6%) had grade 4 or 5 shunts with Valsalva
(Table II). Most patients had more severe shunting after
Valsalva, and all patients who were classified as grade 5 at
rest were also grade 5 after Valsalva.
EMA was then performed using Varisolve in 82 pa-
tients, and 61 had an R-L shunt. After Varisolve injection
(median volume, 18 mL; range, 6-24 mL), 54 of the
patients (89%) with an R-L shunt hadHITS compared with
six of 21 patients (29%) without an R-L shunt on TCD (P
 .001, Fisher’s exact test). No patients had symptoms or
signs of cerebral embolization. Despite the large volumes of
microfoam injected, the number of bubbles was similar to
that during the diagnostic test.
DISCUSSION
In this study in patients with varicose veins due to GSV
incompetence (CEAP C3-5), R-L shunting was detected at
more than twice the anticipated prevalence, 58.8% (95%
CI, 52.5-65.1). The presence of R-L shunting on TCD
was, unsurprisingly, a strong predictor of HITS during
subsequent EMA, even thoughValsalva and coughing were
discouraged. This high prevalence is unlikely to be ac-
counted for by false-positive results, and only a small pro-
portion of these shunts are likely to have resulted from the
transpulmonary passage of contrast.
The previous gold standard for PFO diagnosis has been
TEE with contrast; however, contrast TCD as used in this
study has been shown to be as sensitive as TEE20 while
being less invasive and expensive, quantitative, and more
patient-friendly. It was impossible to apply in only three
patients (2%) due to absence of a temporal bone window.
Agitated saline with a small amount of the patient’s own
blood was used as the ultrasound contrast. Although not
documented in the literature, the blood acts as a surfactant
to improve bubble stability and create contrast of sufficient
duration, and it minimizes false-negative results.
The inclusion of a well-performed standardized Val-
salva maneuver is equally important, as demonstrated by
finding an additional 45 shunts, of which nine were higher-
Table II. Right-to-left shunt severity by Spencer grading
at rest and with Valsalva
Spencer grade
At rest
0 1 2 3 4 5 Total
Valsalva
0 91 15 0 0 0 0 106
1 20 9 0 0 0 0 29
2 10 5 0 0 2 0 16
3 6 8 1 0 0 0 15
4 5 4 5 7 4 0 24
5 4 3 4 6 3 8  1a 28
Total 136 44 10 13 9 9 220  1
aOne patient grade 5 at rest was not retested with Valsalva.grade shunts. Although 15 patients were grade 1 (1 to 5emboli) at rest and were subsequently negative on Valsalva,
this could have resulted from chance, a very small shunt, a
false-positive embolus identification at rest, or a shunt that
was inhibited by Valsalva, which might be the case of a
transpulmonary shunt or the surge of blood free of contrast
from the inferior vena cava impinging on the PFO aperture.
TCD has the disadvantage, however, of being incapa-
ble of differentiating the location of the shunt, whether
intracardiac or intrapulmonary. In the diagnostic part of
this study, only bubbles reaching the middle cerebral artery
within 15 cardiac cycles were counted, reducing the poten-
tial effect of any transpulmonary passage. Reliable differen-
tiation between a PFO and a pulmonary shunt is not
possible, however,21 and the transit times associated with
pulmonary shunts are comparable with those of cardiac
shunts.22 Transpulmonary passage may account for some
patients having HITS after treatment. In one study,
transpulmonary shunt was found in four of 49 patients
(8%), whereas a PFO was present in 19 (38%).23
During EMA for varicose veins, bubbles released into
the circulation will flow to the heart through the inferior
vena cava and will be streamed against the intra-atrial
septum. This route of introduction of contrast has been
shown to increase the sensitivity of R-L shunt detection24
and could account for other shunt-negative patients having
cerebral bubble emboli through a previously missed PFO.
CONCLUSION
The high prevalence of R-L shunt seen in this popula-
tion of CEAP C3-5 patients was 58.9% and confirms earlier
study observations15 and that of Neuhardt et al,25 in which
the presence of cardiac and cerebral HITS was 30% in an
unselected varicose vein population. The high prevalence of
R-L shunt in patients with symptomatic GSV incompe-
tence and varicose veins is important because it indicates
that more than half of the symptomatic varicose vein pa-
tients being treated with foam sclerotherapy are likely to be
exposed to cerebral bubble embolization. Continued cau-
tion is indicated because bubble emboli are the presumed
cause of neurologic symptoms and stroke in published case
reports after foam sclerotherapy.15,16 The results from this
study will be compared with the prevalence of an age- and
sex-matched control population, and in parallel, common
genetic markers are being sought to shed further light on
this observation. This association, if confirmed, is very
intriguing as to its mechanism, and if it is genetic, might
shed light on the cause of one or both conditions.
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